SCHEMBL10286170

SCHEMBL10286170

O=C1CCCCc2c(-c3ccccc3)ccnc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PARP10 Q53GL7 1/20 0.41
PARP11 Q9NR21 1/20 0.41
HSD17B10 Q99714 3/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
HPGD P15428 2/20 0.39
HTT P42858 3/20 0.38
LMNA P02545 2/20 0.38
GRM4 Q14833 1/20 0.38
ALOX15 P16050 1/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
BRD4 O60885 1/20 0.37
USP30 Q70CQ3 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
PDE3B Q13370 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL883079 0.97 KMT2A (0.44) KMT2AL3MBTL1PARP10PARP11HSD17B10
SCHEMBL12087417 0.81 LRRK2 (0.42) KMT2AL3MBTL1PARP10PARP11HSD17B10
SCHEMBL9166764 0.76 GRM4 (0.58) L3MBTL1PARP10PARP11HSD17B10KDM4E
SCHEMBL10286174 0.74 NOS3 (0.36) KMT2APARP10PARP11HSD17B10KDM4E
SCHEMBL23273185 0.74 PARP10 (0.54) KMT2APARP10PARP11MEN1LMNA
SCHEMBL10286126 0.74 KMT2A (0.44) KMT2AL3MBTL1HSD17B10KDM4EALDH1A1
SCHEMBL345620 0.73 KMT2A (0.50) KMT2AL3MBTL1HSD17B10KDM4EALDH1A1
SCHEMBL10286197 0.73 NOS3 (0.43) BRD4
SCHEMBL10286114 0.73 BCL2L1 (0.37) KMT2AL3MBTL1HSD17B10KDM4EALDH1A1
SCHEMBL30775203 0.72 PARP10 (0.45) PARP10PARP11HSD17B10ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2013-04-25 US disclosed
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2013-04-25 US disclosed
WO-2012001040-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES MSR1, DDT, MPO KMT2A 1808/4885L3MBTL1 850/4885PARP10 3375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.